Kits Eyecare Stock Current Valuation
| KITS Stock | CAD 8.95 0.24 2.61% |
Valuation analysis of Kits Eyecare helps investors to measure Kits Eyecare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 3rd of December 2024, Enterprise Value Over EBITDA is likely to grow to 110.34. Also, Enterprise Value Multiple is likely to grow to 110.34. Fundamental drivers impacting Kits Eyecare's valuation include:
Price Book 5.3002 | Enterprise Value 276.4 M | Enterprise Value Ebitda 66.398 | Price Sales 1.9335 | Forward PE 64.1026 |
Overvalued
Today
Please note that Kits Eyecare's price fluctuation is somewhat reliable at this time. Calculation of the real value of Kits Eyecare is based on 3 months time horizon. Increasing Kits Eyecare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Kits Eyecare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kits Stock. However, Kits Eyecare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.95 | Real 7.82 | Hype 8.92 | Naive 9.25 |
The intrinsic value of Kits Eyecare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kits Eyecare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kits Eyecare helps investors to forecast how Kits stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kits Eyecare more accurately as focusing exclusively on Kits Eyecare's fundamentals will not take into account other important factors: Kits Eyecare Company Current Valuation Analysis
Kits Eyecare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Kits Eyecare Current Valuation | 276.41 M |
Most of Kits Eyecare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kits Eyecare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Kits Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Kits Eyecare is extremely important. It helps to project a fair market value of Kits Stock properly, considering its historical fundamentals such as Current Valuation. Since Kits Eyecare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kits Eyecare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kits Eyecare's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Kits Eyecare has a Current Valuation of 276.41 M. This is 98.47% lower than that of the Specialty Retail sector and 99.36% lower than that of the Consumer Discretionary industry. The current valuation for all Canada stocks is 98.34% higher than that of the company.
Kits Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kits Eyecare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kits Eyecare could also be used in its relative valuation, which is a method of valuing Kits Eyecare by comparing valuation metrics of similar companies.Kits Eyecare is currently under evaluation in current valuation category among its peers.
Kits Fundamentals
| Return On Equity | -0.002 | ||||
| Return On Asset | 0.0039 | ||||
| Profit Margin | (0.0007) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 276.41 M | ||||
| Shares Outstanding | 31.58 M | ||||
| Shares Owned By Insiders | 75.76 % | ||||
| Shares Owned By Institutions | 4.19 % | ||||
| Number Of Shares Shorted | 9.08 K | ||||
| Price To Book | 5.30 X | ||||
| Price To Sales | 1.93 X | ||||
| Revenue | 120.51 M | ||||
| Gross Profit | 29.25 M | ||||
| EBITDA | 2.34 M | ||||
| Net Income | (2.21 M) | ||||
| Cash And Equivalents | 18.79 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 15.39 M | ||||
| Debt To Equity | 0.40 % | ||||
| Current Ratio | 1.80 X | ||||
| Book Value Per Share | 1.69 X | ||||
| Cash Flow From Operations | 2.4 M | ||||
| Short Ratio | 0.12 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 15.5 | ||||
| Number Of Employees | 143 | ||||
| Beta | 0.36 | ||||
| Market Capitalization | 282.61 M | ||||
| Total Asset | 87.64 M | ||||
| Retained Earnings | (27.91 M) | ||||
| Working Capital | 9.46 M | ||||
| Net Asset | 87.64 M |
About Kits Eyecare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kits Eyecare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kits Eyecare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kits Eyecare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Kits Stock
Kits Eyecare financial ratios help investors to determine whether Kits Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.